Detalles de la búsqueda
1.
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study.
Expert Opin Pharmacother
; 23(16): 1855-1863, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352762
2.
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer.
Ther Adv Med Oncol
; 13: 17588359211045845, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819997
3.
Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus.
Clin Pharmacol Drug Dev
; 9(1): 74-86, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392840
4.
Impact of Insulin Tregopil and Its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-Label, Placebo-Controlled, Crossover Study.
Clin Transl Sci
; 12(3): 276-282, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592549
Resultados
1 -
4
de 4
1
Próxima >
>>